Assignee

Sangamo Therapeutics, Inc.

Patents = 145

Trademarks = 2

Forward Citations = 521

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

297 inventors (with patents filed for the assignee):

Sangamo Therapeutics, Inc. is a biotechnology company focused on translating groundbreaking genome editing technology into novel therapeutics for genetic diseases. The company aims to create transformative genomic medicines using their proprietary zinc finger nuclease (ZFN) and CRISPR/Cas9 platforms. Sangamo's goal is to develop innovative treatments for a wide range of diseases, including genetic disorders, neurodegenerative diseases, and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com